FLAZAIRE (Sandoz Pty Ltd)
Product name
FLAZAIRE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
121 (255 working days)
Active ingredients
azelastine hydrochloride, fluticasone propionate
Registration type
New generic medicine
Indication
Symptomatic treatment of moderate to severe allergic rhinitis for up to 6 months